Allianz Asset Management Gmb H Aurinia Pharmaceuticals Inc. Transaction History

Allianz Asset Management Gmb H

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$17.78 - $33.08 $212,737 - $395,802	11,965 New	11,965 $217,000
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $332,250 - $482,427	-33,225 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$12.3 - $18.73 $2.17 Million - $3.3 Million	-176,147 Reduced 84.13%	33,225 $432,000
Q4 2020 Feb 16, 2021	SELL	$12.94 - $16.05 $41,019 - $50,878	-3,170 Reduced 1.49%	209,372 $2.89 Million
Q3 2020 Nov 13, 2020	SELL	$13.19 - $16.66 $435,441 - $549,996	-33,013 Reduced 13.44%	212,542 $3.12 Million
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $145,294 - $188,615	10,290 Added 4.37%	245,555 $3.97 Million
Q1 2020 May 14, 2020	BUY	$11.34 - $21.46 $224,815 - $425,444	19,825 Added 9.2%	235,265 $3.38 Million
Q4 2019 Feb 13, 2020	BUY	$3.88 - $21.42 $835,907 - $4.61 Million	215,440 New	215,440 $4.37 Million

191

56.2M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.03B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.